Lovastatin-producing endophytic fungus isolated from a medicinal plant Solanum xanthocarpum
Authors:
- 6 March 2015
- journal article
- Published by Taylor & Francis in Natural Product Research
- Vol. 29 (24) , 2282-2286
Abstract
Lovastatin is a potent drug for lowering blood cholesterol. An endophytic fungus Phomopsis vexans was isolated from the healthy leaf tissues of Solanum xanthocarpum, a medicinal plant, and screened for lovastatin production. The fungus was identified by their characteristic cultural morphology and molecular analysis. The strain had a component with the same TLC Rf value and HPLC retention time as authentic lovastatin. The presence of lovastatin was further confirmed by FT-IR, UV, (1)H, (13)C NMR and LC-MS analyses. The amount of lovastatin produced by this endophytic fungus was quantified to be 550 mg/L, and thus the fungus can serve as a potential material to improve the production of lovastatin.Keywords
This publication has 28 references indexed in Scilit:
- Lovastatin Production byAspergillus terreusUsing Agro-Biomass as Substrate in Solid State FermentationJournal of Biomedicine and Biotechnology, 2012
- Bioactive natural products from endophytes: A reviewApplied Biochemistry and Microbiology, 2008
- Natural Products from Plant-Associated Microorganisms: Distribution, Structural Diversity, Bioactivity, and Implications of Their OccurrenceJournal of Natural Products, 2006
- Production of lovastatin by Aspergillus terreus: effects of the C:N ratio and the principal nutrients on growth and metabolite productionEnzyme and Microbial Technology, 2003
- Production and Purification of Statins from Pleurotus ostreatus (Basidiomycetes) StrainsZeitschrift für Naturforschung C, 2003
- Lovastatin Biosynthesis by Aspergillus terreus in a Chemically Defined MediumApplied and Environmental Microbiology, 2001
- 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors and the Risk of CancerArchives of internal medicine (1960), 2000
- Current and future treatment of hyperlipidemia: the role of statinsThe American Journal of Cardiology, 1998
- Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proceedings of the National Academy of Sciences, 1980
- ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.The Journal of Antibiotics, 1976